He remained on 5 mg weekly for 6 months before moving to his final dose of 7.5 mg weekly
GLP-1 agonists explained Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) represent the most successful weight loss drugs ever developed
But smaller doses are not simply lighter versions of full treatment and may not help you lose the weight you want, says Zhaoping Li, MD, a professor of medicine and the chief of the division of clinical nutrition at UCLA Health in California
However, taking the drug may pose other health risks for older adults that arent yet well understood because of the small number of participants over age 65 in the Ozempic clinical trials
Fabiola Olivieri, Francesco Prattichizzo, Fabrizia Lattanzio, Anna Rita Bonfigli, Liana Spazzafumo Ageing Research Reviews.2023